World Library  
Flag as Inappropriate
Email this Article

Nucleic acid inhibitor

Article Id: WHEBN0020103749
Reproduction Date:

Title: Nucleic acid inhibitor  
Author: World Heritage Encyclopedia
Language: English
Subject: Rifapentine, Rifabutin, Nitrofuran, Danofloxacin, Aldesulfone sodium
Collection: Antibiotics, Nucleic Acid Inhibitor Antibiotics
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Nucleic acid inhibitor

Image illustrates DNA, RNA, and protein synthesis. The first two are nucleic acids.

A nucleic acid inhibitor is a type of antibacterial that acts by inhibiting the production of nucleic acids. There are two major classes: DNA inhibitors and RNA inhibitors.[1] The antifungal flucytosine acts in a similar manner.

Contents

  • DNA inhibitors 1
  • RNA inhibitors 2
  • Antifolates (DNA, RNA, and protein) 3
  • References 4

DNA inhibitors

DNA inhibitors (such as the quinolones, acting upon DNA gyrase as a topoisomerase inhibitor)[2]

Another group of DNA inhibitors, including nitrofurantoin and metronidazole, act upon anaerobic bacteria.[3] These act by generating metabolites that are incorporated into DNA strands, which then are more prone to breakage.[4] These drugs are selectively toxic to anaerobic organisms, but can affect human cells.

RNA inhibitors

Antifolates (DNA, RNA, and protein)

Antifolates act primarily as inhibitors of both RNA and DNA, and are often grouped with nucleic acid inhibitors in textbooks. However, they also act indirectly as protein synthesis inhibitors (because tetrahydrofolate is also involved in the synthesis of amino acids serine and methionine), so they are sometimes considered as their own category, antimetabolites.[5] However, the term "antimetabolite", when used literally, can apply to many different classes of drugs.

References

  1. ^ http://www.ccsf.edu/Departments/Biology/ctoebe/antibiotics.htm
  2. ^ a b http://pathmicro.med.sc.edu/mayer/antibiot.htm
  3. ^ Ralph, E. D. (1978). "The bactericidal activity of nitrofurantoin and metronidazole against anaerobic bacteria". The Journal of antimicrobial chemotherapy 4 (2): 177–184.  
  4. ^ P. Denyer, Stephen; Hodges, Norman A.; P. Gorman, Sean (2004). Hugo and Russell's pharmaceutical microbiology. Oxford: Blackwell Science. p. 215.  
  5. ^ http://www.life.umd.edu/classroom/bsci424/Chemotherapy/AntibioticMechanisms.htm


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.